
Increasing discourses on person-centered care, psychologically informed approaches, and the social complexity of physiotherapy practice have bolstered interest in broadened understandings of ethical theories and relational approaches. Calls to include ‘relational ethics’ in decision-making when faced with ethical dilemmas in physiotherapy practice seek to balance traditional biomedical approaches with humanistic dimensions. In this perspective paper, we extend current arguments and ethical models, drawing on findings from recent research that we conducted on what constitutes a good physiotherapist and the physiotherapy therapeutic relationship. The various qualities and practices identified by practitioners as important to both concepts align with a relational ethics perspective. Our purpose is to discuss the qualities and practices identified in our investigations to advance particular ways of reasoning and acting, which we propose as fruitful directions for fostering ethical physiotherapy practice. These approaches move beyond traditional conceptions by balancing normative, technical approaches to practice with an ethic of care. We provide a brief overview of traditional Western bioethical approaches and relational ethics approaches before focusing on Tronto’s ethic of care theory. In this perspective paper, we describe the components of Miciak’s Physiotherapy Therapeutic Relationship Framework and what constitutes a good physiotherapist, and consider how these two conceptual framings align with each other and with Tronto’s ethic of care theory. Then, we illustrate how the physiotherapeutic relationship, the qualities and practices of a good physiotherapist, and Tronto’s ethic of care theory may be enacted in physiotherapy through brief description and a case study. We contend that the qualities and practices identified in our studies may contribute to the refinement of ethical frameworks, inform educational approaches to practice and ethics education, and most importantly, shape therapist-patient interactions as clinicians navigate ethical deliberations about what ought to be done in situations of uncertainty.
Background Type 2 diabetes mellitus (T2DM) is accompanied by obesity and elevated body mass index (BMI), which may be associated with poorer physical function and quality of life (QOL). However, associations of BMI with muscle strength, functional capacity, balance, and QOL have not been comprehensively evaluated together in T2DM. Purpose To evaluate associations of BMI with muscle strength, functional capacity, balance, and QOL in patients with T2DM. Methods Patient characteristics were recorded. Body composition, muscle strength, functional capacity, balance, and QOL were assessed using validated measures. Bivariate Pearson correlations were supplemented by partial correlations controlling for age, sex, height, diabetes duration, glycated hemoglobin A1c (HbA1c), and insulin use. Results Fifty patients with T2DM were included (age: 52.90 +/- 9.27 years; BMI: 33.76 +/- 7.18 kg/m(2)). In unadjusted analyses, higher BMI was associated with greater adiposity, lower skeletal muscle mass percentage and handgrip strength, shorter 6-minute walk test (6MWT) distance, lower Berg Balance Scale scores, and poorer QOL, but not with quadriceps strength, resting metabolic rate, Biodex balance parameters, or several QOL subdomains. After adjustment, BMI remained associated with body fat percentage (partial r = 0.854, p < .001), skeletal muscle mass percentage (partial r = -0.665, p < .001), 6MWT distance (partial r = -0.545, p < .001), and Nottingham Health Profile (NHP) pain (partial r = 0.426, p = .004), mobility (partial r = 0.440, p = .003), and total score (partial r = 0.351, p = .019). Associations with handgrip strength (p = .728) and Berg Balance test score were no longer significant (p = .069). Conclusion After adjustment for confounders, higher BMI remained associated with higher body fat percentage, lower skeletal muscle mass percentage, shorter 6MWT distance, and poorer QOL, whereas associations with handgrip strength and functional balance were attenuated. BMI-related functional findings should be interpreted cautiously in light of potential confounding.
Background: Altered resting scapular position is commonly observed in people with chronic non-specific neck pain. However, clinical characteristics associated with different patterns of resting scapular dysfunction remain unclear. Objective: To compare neck pain characteristics, associated symptoms, and physical impairments among people with chronic non-specific neck pain with resting scapular downward rotation (SDR), those with resting scapular protraction, those without resting scapular dysfunction, and asymptomatic controls without resting scapular dysfunction. Methods: A total of 144 participants were recruited (36 in each group). Outcome measures included neck pain characteristics (intensity, disability, duration, and area), associated symptoms (headache and dizziness), and physical impairments (cervical range of motion (ROM), flexion rotation test(FRT), cervical and shoulder joint position errors (JPEs), and pressure pain thresholds (PPTs) at C5-C6 zygapophyseal joints, upper trapezius, levator scapulae, and tibialis anterior). Results: All neck pain groups showed greater pain, symptoms, and physical impairments than controls (all p < .01, eta(2)(P) = 0.28-0.74). The neck pain group with resting SDR demonstrated the greatest impairments, including higher pain intensity, upper and whole neck pain, headache and dizziness, reduced cervical ROM and FRT range, increased cervical and shoulder JPEs, and lower PPTs at local and remote sites (all p < .01, eta(2)(p) = 0.23-0.72). Conversely, the neck pain group with resting scapular protraction exhibited clinical features similar to those without resting scapular dysfunction, including lower neck and upper trapezius pain, decreased cervical ROM, increased cervical and shoulder JPEs, and reduced PPTs at local sites (all p < .01, eta(2)(P) = 0.28-0.74). Conclusion: Patterns of resting scapular dysfunction may represent distinct clinical phenotypes in people with chronic non-specific neck pain. Resting SDR was associated with more severe and widespread clinical deficits, highlighting the importance of considering both biomechanical and pain mechanisms in clinical evaluation and management of this population.
The impact of muscle quality on the fear of falling, lower extremity functionality, and their complex interaction, particularly in older women, is uncertain. This cross-sectional study aimed to investigate the association of muscle quality with fear of falling and lower extremity functionality in older women. This study evaluated 168 age-matched older adults (women = 84, men = 84). Outcome measures included the Muscle Quality Index (MQI), Lower Extremity Functional Scale (LEFS), and Fall Efficiency Scale-International (FES-I). Correlation and linear regression analyses were used to examine the associations among muscle quality, lower extremity function, and fear of falling. Women scored lower than men on the MQI (44.56 ± 18.20 vs 55.88 ± 22.11 W) and LEFS (46.92 ± 12.86 vs 54.32 ± 14.01), and higher on the FES-I (29.19 ± 8.14 vs 24.25 ± 7.66; all p < .001). Among women, LEFS and FES-I were strongly correlated (rho = −0.730). Higher MQI was associated with lower FES-I (B = −0.187, β = −0.417) and higher LEFS (B = 0.325, β = 0.460), and higher LEFS was associated with lower FES-I (B = −0.442, β = −0.698) (all p < .001). All three associations persisted after adjustment. Compared with age-matched men, older women had poorer muscle quality, poorer lower extremity function, and greater fear of falling. In women, both poorer muscle quality and lower extremity function were associated with greater fear of falling; the association was stronger for lower extremity function. These findings may indicate a need for a sex-specific and multidimensional rehabilitation model. Clinicians should prioritize interventions that strategically target both muscle quality and functional mobility to preemptively mitigate the unique physical and psychological risks that threaten aging women’s quality of life. ClinicalTrials.gov NCT05758792